Skip to main content
Log in

Where do we go from here? Relations between the medical profession and the pharmaceutical industry

  • Editor’s Commentary
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Alpert JS, Furman S, Smaha L: Conflicts of interest. Arch Int Med 2002, 162:635–637.

    Article  Google Scholar 

  2. Parmley WW: Full disclosure: the antidote to conflict of interest. J Am Coll Cardiol 2000, 35:1693.

    Article  PubMed  CAS  Google Scholar 

  3. Bodenheimer T: Uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med 2000, 342:1539–1544.

    Article  PubMed  CAS  Google Scholar 

  4. Angell M: Is academic medicine for sale? N Engl J Med 2000, 342:1516–1518.

    Article  PubMed  CAS  Google Scholar 

  5. Cech TR, Leonard JS: Conflicts of interest: moving beyond disclosure. Science 2001, 291:989.

    Article  PubMed  CAS  Google Scholar 

  6. Moses H, Martin JB: Academic relationships with industry: a new model for biomedical research. JAMA 2001, 285:933–935.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alpert, J.S. Where do we go from here? Relations between the medical profession and the pharmaceutical industry. Curr Cardiol Rep 5, 169–170 (2003). https://doi.org/10.1007/s11886-003-0043-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-003-0043-y

Navigation